2.03 USD
▲+0.05+2.53%
盘后 2.01 0.00%
2026-09-16
市值
$13.52M
市盈率
—
EPS
-6.65
股息率
—
52 周区间
1.87 – 36.00
成交量
17.64K
Beta
1.07
目标价
50.00
52W 低 1.8752W 高 36.00
价格走势
公司简介
CalciMedica, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for illnesses caused by inflammatory and immunologic processes and direct cellular damage. Its lead product candidate comprises Auxora, an intravenous formulated small molecule calcium release-activated calcium (CRAC) channel inhibitors for the treatment of acute pancreatitis, asparaginase-induced pancreatic toxicity, and acute kidney injury, as well as severe COVID-19 pneumonia. The company also develops Auxora for the treatment of ulcerative colitis, traumati...